Short interest in Antibe Therapeutics Inc (OTC:ATBPF) decreased during the last reporting period, falling from 65.10K to 65.10K. This put -% of the company's publicly available shares short.

Short interest for Antibe Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Antibe Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of - shares traded per day, it would take 999.99 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.